Life Sciences Insights
Life sciences newsletter - Vol. 1 - Issue 5
Welcome to the fifth Belgian newsletter for the Life Sciences industry, published by Deloitte! We publish this newsletter every 2 months and we hope this will be an enjoyable and productive reading – please contact us if you have any questions or wish to discuss any of the topics further.
- How prepared is your organization to continue business through a pandemic such as the Mexican flu?
On June 11, 2009, the World Health Organization (WHO) raised the alert level to phase 6 ‗pandemic‘. Evidence from multiple outbreak sites demonstrates that the H1N1 pandemic virus has rapidly spread and is now the dominant influenza strain in most parts of the world. The H1N1 pandemic will persist in the coming months as the virus continues to move through susceptible populations. History has demonstrated that the threat of a pandemic is real. In the 20th century, there were three pandemics. The 1918 pandemic led to at least 50 million deaths worldwide.
- Business Partners in the Life Sciences Sector: Greater Value with Greater Transparency?
Some observations and findings from compliance reviews performed on business partner contracts.
- Destination 2025?
Focus on the future of the Biologic and Biopharmaceutical Industry
- Managing talent in a turbulent economy – Clearing the hurdles to recovery
This is the 3rd piece of our survey among global top executives, and a special focus on life sciences executives.
- Did you know? Some insights, surprises …